Back to all cases
Novartis
🌐 Belgium·2019
Collected
DBRPharmaceuticals
Case Summary
Zoliflodacin showed non-inferiority to ceftriaxone combined with azithromycin in a phase 3 trial.
Quantified Results
metric: 23%
Source
- Title
- Boundary Objects as a Learning Mechanism for Sustainable Development Goals—A Case Study of a Japanese Company in the Chemical Industry
- Type
- academic paper
- Year
- 2019
- Confidence Score
- 80%